Kringle Pharma, Inc.
クリングルファーマ(株)
2026/10/09 19:27 Updated
Market Cap:
$32.9M (¥5.2B)
Stock Price:
$4.08 (¥645)
Exchange Rate: 1 USD = ¥158.23
Submission of the Clinical Trial Plan for a Phase III Additional Study of HGF (Hepatocyte Growth Factor) in the Acute Phase of Spinal Cord Injury
Kringle Pharma, Inc.
Company overview · Stock price · Financial data · All IR
